Proteomics

Dataset Information

0

Modeling CRL4A ligase complex to predict target protein ubiquitination induced by CRBN-recruiting PROTACs


ABSTRACT: PROteolysis TArgeting Chimeras (PROTACs) are bifunctional small molecules that can simultaneously recruit target protein and E3 ligase to form a ternary complex (target protein / PROTAC / E3 ligase), leading to target protein ubiquitination and degradation via the Ubiquitin-Proteasome System (UPS). PROTACs have gained increasing attention in recent years due to certain advantages over traditional therapeutic modalities enabling targeting of previously "undruggable" proteins. To better understand the mechanism of PROTAC-induced Target Protein Degradation (TPD), several computational approaches have recently been developed to study and predict ternary complex formation. However, mounting evidence suggests that ubiquitination can also be a rate-limiting step in PROTAC induced TPD. Here, we propose a structure-based computational approach to predict target protein ubiquitination induced by CRBN-based PROTACs,

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Early Embryonic Cell

SUBMITTER: Aman Makaju  

LAB HEAD: Sara Humphreys

PROVIDER: PXD030213 | Pride | 2022-05-19

REPOSITORIES: Pride

altmetric image

Publications

Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.

Bai Nan N   Riching Kristin M KM   Makaju Aman A   Wu Hao H   Acker Timothy M TM   Ou Shu-Ching SC   Zhang Yaru Y   Shen Xiaomeng X   Bulloch Daryl N DN   Rui Huan H   Gibson Bradford W BW   Daniels Danette L DL   Urh Marjeta M   Rock Brooke M BM   Humphreys Sara C SC  

The Journal of biological chemistry 20220129 4


PROteolysis TArgeting Chimeras (PROTACs) are hetero-bifunctional small molecules that can simultaneously recruit target proteins and E3 ligases to form a ternary complex, promoting target protein ubiquitination and degradation via the Ubiquitin-Proteasome System (UPS). PROTACs have gained increasing attention in recent years due to certain advantages over traditional therapeutic modalities and enabling targeting of previously "undruggable" proteins. To better understand the mechanism of PROTAC-i  ...[more]

Similar Datasets

2023-07-10 | PXD038298 | Pride
2023-07-10 | PXD038503 | Pride
2022-09-22 | PXD036865 | Pride
2024-05-23 | PXD043560 | Pride
2022-08-08 | PXD024661 | Pride
2023-12-18 | PXD047347 | Pride
2022-09-14 | PXD036224 | Pride
2024-09-13 | GSE245926 | GEO
2024-09-13 | GSE245925 | GEO
2022-08-12 | PXD021505 | Pride